HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Usefulness of newly developed 99mTc-labeled STA-R12 for tumor imaging].

Abstract
We synthesized four new tumor imaging agents, 99mTc-labeled metalloporphyrins (99mTc-STA-R12, -STA-R21, -STA-RN101 and -ATN-12) for the tumor imaging. We compared the differences of tumor imaging potency among these agents in CDF1 mice implanted with colon 26 tumor. Tumor images with these agents were obtained by using digital gamma-camera (RC135-E, Hitachi, Tokyo) and the biodistributions were analyzed by computerized medical radionuclide imageanalyser (RP-200, Hitachi, Tokyo). The highest tumor organ ratio and the excellent tumor image were obtained by 99mTc-STA-R12 (13,17-Bispropanyl aspartic acid-3-ethenyl-8-[N,N',N",N"-tetrakis (carboxylmethyl-2,7,12,18-tetramethyl-porphyrinato]-manga nes e(III). The maximum concentration of 99mTc-STA-R12 in tumor tissue was observed at around 120 minutes after i.v. injection. On the contrary, the uptake rates of other organs and tissues such as liver, brain, muscle, lung, bone and blood continuously decreased. The rapid accumulation of STA-R12 in cancer tissue and the clearance from other tissue suggested a potential usefulness of this compound for tumor imaging agent.
AuthorsS Nakajima, N Shuke, T Aburano, S Ishikawa, J Sato, I Sakata, T Takemura
JournalKaku igaku. The Japanese journal of nuclear medicine (Kaku Igaku) Vol. 31 Issue 11 Pg. 1379-83 (Nov 1994) ISSN: 0022-7854 [Print] Japan
PMID7837707 (Publication Type: Journal Article)
Chemical References
  • 13,17-bispropanoylaspartic acid-3-ethenyl-8-((N,N',N'', N'''-tetrakis(carboxylmethyl)diethylenetriaminoacetyloxy)methyl-2,7,12,18-tetramethylporphyrinato)manganese(III)
  • Metalloporphyrins
  • Technetium
Topics
  • Animals
  • Evaluation Studies as Topic
  • Metalloporphyrins
  • Mice
  • Mice, Inbred Strains
  • Neoplasms, Experimental (diagnostic imaging)
  • Radionuclide Imaging
  • Technetium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: